Search

Search Constraints

You searched for: Author/Creator Lopalco, Giuseppe

Search Results

23. Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study. Issue 5 (26th August 2017)

24. Delights and let‐downs in the management of tumor necrosis factor receptor‐associated periodic syndrome: the canakinumab experience in a patient with a high‐penetrance T50M TNFRSF1A variant. (18th December 2014)

25. Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI). Issue 2 (23rd July 2020)

27. Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry. (7th May 2021)

28. Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. Issue 1 (January 2017)

30. Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study. Issue 5 (May 2016)